GLP-1 +3 Jul 28, 2026 7 min read Weight loss remains the star of the show, but cardiovascular data was underpowered GLP-1 +1 Jul 16, 2026 10 min read A guest post by Jen Can NuSH on liver concerns and small molecule GLP1 medications GLP-1 +3 Jul 2, 2026 14 min read Orals, Triples, Biologics and even more data from ADA 2026 GLP-1 +4 Jul 1, 2026 5 min read New phase 1b data shows incredible weight loss GLP-1 +2 Jun 19, 2026 18 min read A tale of dual agonists, glucagon or amylin, who wins the insulin sensitivity race
Although short-term use of unapproved peptides appears to be mostly safe, the larger concern lies with downstream side effects that we just dont know about, says Cushman
In short, it creates weight loss via hormonal signaling, which reduces your appetite, helps you feel full longer, while also delaying gastric emptying and modulating satiety signals in your brain
What matters is how much of the weight lost comes from fat versus lean tissue